{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T15:18:31Z","timestamp":1719328711978},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[1997,1]]},"DOI":"10.1007\/bf01681960","type":"journal-article","created":{"date-parts":[[2005,5,13]],"date-time":"2005-05-13T17:39:20Z","timestamp":1116005960000},"page":"38-43","source":"Crossref","is-referenced-by-count":9,"title":["Dose-finding study of oral metopimazine"],"prefix":"10.1007","volume":"5","author":[{"given":"J\u00f8rn","family":"Herrstedt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tine","family":"Sigsgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helle R.","family":"Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens P.","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mogens","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01681960_CR1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2165\/00003495-199142040-00002","volume":"42","author":"MS Aapro","year":"1991","unstructured":"Aapro MS (1991) 5-HT3 receptor antagonists. An overview of their present status and future potential in cancer chemotherapy-induced emesis. Drugs 42:551\u2013568","journal-title":"Drugs"},{"key":"BF01681960_CR2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0378-4347(00)82597-9","volume":"496","author":"HR Angelo","year":"1989","unstructured":"Angelo HR, Herrstedt J, J\u00f8rgensen M (1989) High-perfomance liquid chromatographic method with fluorescence detection for the simultaneous determination of metopimazine and its acid metabolite in serum. J Chromatogr 496:472\u2013477","journal-title":"J Chromatogr"},{"key":"BF01681960_CR3","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1002\/1097-0142(19871101)60:9<2165::AID-CNCR2820600908>3.0.CO;2-C","volume":"60","author":"BI Carr","year":"1987","unstructured":"Carr BI, Blayney DW, Goldberg DA, Braly P, Metter GE, Doroshow JH (1987) High doses of prochlorperazine for cisplatin-induced emesis: a prospective, random, dose-response study. Cancer 60:2165\u20132169","journal-title":"Cancer"},{"key":"BF01681960_CR4","first-page":"307","volume":"239","author":"M Clavel","year":"1978","unstructured":"Clavel M, Bolot JE, Philippe-Bert J, et al (1978) Double-blind comparative trial with metopimazine (50 mg and 10 mg i.v.) as a preventive treatment for nausea and vomiting attending anticancer drug therapy. Lyon Med 239:307\u2013309","journal-title":"Lyon Med"},{"key":"BF01681960_CR5","first-page":"683","volume":"37","author":"H Debray","year":"1990","unstructured":"Debray H, Giuhard J, Peyramond D, Tron P (1990) Treatment of vomiting in infants and children induced by acute infectious pathology. A comparative study of alizapride versus metopimazine. Ann Pediatrie 37:683\u2013687","journal-title":"Ann Pediatrie"},{"key":"BF01681960_CR6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM198110153051601","volume":"305","author":"RJ Gralla","year":"1981","unstructured":"Gralla RJ, Itri L, Pisko S, et al (1981) Antiemetic efficacy of high dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced vomiting. N Engl J Med 305:905\u2013909","journal-title":"N Engl J Med"},{"key":"BF01681960_CR7","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1200\/JCO.1984.2.7.782","volume":"2","author":"SM Grunberg","year":"1984","unstructured":"Grunberg SM, Gala KV, Lampenfeld M, et al (1984) Comparison of the antiemetic effect of high-dose intravenous metoclopramide and high-dose intravenous haloperidol in a randomized double-blind crossover study. J Clin Oncol 2:782\u2013787","journal-title":"J Clin Oncol"},{"key":"BF01681960_CR8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2125.1990.tb03770.x","volume":"30","author":"J Herrstedt","year":"1990","unstructured":"Herrstedt J, J\u00f8rgensen M, Angelo HR (1990) The effect of food on serum concentrations of metopimazine. Br J Clin Pharmacol 30:237\u2013243","journal-title":"Br J Clin Pharmacol"},{"key":"BF01681960_CR9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00686023","volume":"33","author":"J Herrstedt","year":"1993","unstructured":"Herrstedt J, Hyttel J, Pedersen J (1993) Interaction of the antiemetic metopimazine and anticancer agents with brain dopamine D2, 5-hydroxytryptamine3, histamine H1, muscarine cholinergic and\u03b1 1-adrenergic receptors. Cancer Chemother Pharmacol 33:53\u201356","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF01681960_CR10","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1056\/NEJM199304153281502","volume":"328","author":"J Herrstedt","year":"1993","unstructured":"Herrstedt J, Sigsgaard T, Boesgaard M, et al (1993) Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy. N Engl J Med 328:1076\u20131080","journal-title":"N Engl J Med"},{"key":"BF01681960_CR11","first-page":"250","volume":"307","author":"HD Homesley","year":"1982","unstructured":"Homesley HD, Gainey JM, Jobson VN, et al (1982) Double-blind placebo-controlled study of metoclopramide in cisplatin-induced emesis. N Engl J Med 307:250\u2013251","journal-title":"N Engl J Med"},{"key":"BF01681960_CR12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1177\/030006057800600311","volume":"6","author":"L Israel","year":"1978","unstructured":"Israel L, Rodary C (1978) Treatment of nausea and vomiting related to anticancerous multiple combination chemotherapy: results of two controlled studies. J Int Med Res 6:236\u2013240","journal-title":"J Int Med Res"},{"key":"BF01681960_CR13","first-page":"1012","volume":"70","author":"MG Kris","year":"1992","unstructured":"Kris MG, Tyson LB, Clark RA, Gralla RJ (1992) Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and review of completed trials to manage delayed emesis. Cancer 70:1012\u20131016","journal-title":"Cancer"},{"key":"BF01681960_CR14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1476-5381.1986.tb10228.x","volume":"88","author":"WD Miner","year":"1986","unstructured":"Miner WD, Sanger GJ (1986) Inhibition of cisplatin-induced vomiting by selective 5-hydroxytryptamine M-receptor antagonism. Br J Pharmacol 88:497\u2013499","journal-title":"Br J Pharmacol"},{"key":"BF01681960_CR15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(19)33898-3","volume":"57","author":"CG Moertel","year":"1969","unstructured":"Moertel CG, Reitemeier RJ (1969) Controlled clinical studies of orally administered antiemetic drugs. Gastroenterology 57:262\u2013268","journal-title":"Gastroenterology"},{"key":"BF01681960_CR16","first-page":"283","volume":"57","author":"CG Moertel","year":"1973","unstructured":"Moertel CG, Reitemeier RJ (1973) Controlled studies of metopimazine for the treatment of nausea and vomiting. J Clin Pharmacol 57:283\u2013287","journal-title":"J Clin Pharmacol"},{"key":"BF01681960_CR17","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/0277-5379(89)90104-1","volume":"25","author":"IN Olver","year":"1989","unstructured":"Olver IN, Webster LK, Bishop JF, et al (1989) A dose finding study of prochlorperazine as an antiemetic for cancer chemotherapy. Eur J Cancer Clin Oncol 25:1457\u20131461","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF01681960_CR18","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/0959-8049(92)90006-N","volume":"28A","author":"IN Olver","year":"1992","unstructured":"Olver IN, Wolf M, Laidlaw C, et al (1992) A randomised double-blind study of high-dose intravenous prochlorperazine versus high-dose metoclopramide as antiemetics for cancer chemotherapy. Eur J Cancer 28A:1798\u20131802","journal-title":"Eur J Cancer"},{"key":"BF01681960_CR19","first-page":"962","volume":"12","author":"C Seigneuric","year":"1983","unstructured":"Seigneuric C, Plantavid M, Sorbette F, et al (1983) Extrapyramidal syndrome. Possible role of metopimazine (letter). Presse Med 12:962\u2013963","journal-title":"Presse Med"},{"key":"BF01681960_CR20","volume-title":"Nonparametric statistics for the behavioral sciences","author":"S Siegel","year":"1988","unstructured":"Siegel S, Castellan NJ Jr (1988) Nonparametric statistics for the behavioral sciences. McGraw-Hill, New York"},{"key":"BF01681960_CR21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/clpt.1992.142","volume":"52","author":"A Tonkin","year":"1992","unstructured":"Tonkin A, Wing L (1992) Aging and susceptibility to drug-induced orthostatic hypotension. Clin Pharmacol Ther 52:277\u2013285","journal-title":"Clin Pharmacol Ther"},{"key":"BF01681960_CR22","first-page":"286","volume":"7","author":"C Vallejo","year":"1988","unstructured":"Vallejo C, Rabinovich M, Leone B, et al (1988) Toxicity and dose-response of intravenous (i.v.) metopimazine (MTZ) as preventive of highdose cisplatin (CDDP)-induced emesis. Proc Am Soc Clin Oncol 7:286","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01681960.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01681960\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01681960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T09:44:57Z","timestamp":1586252697000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01681960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["BF01681960"],"URL":"https:\/\/doi.org\/10.1007\/bf01681960","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1]]}}}